Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center, Single-arm, Open-label Long-term Study Assessing the Safety, Tolerability, and Effectiveness of Macitentan in Fontan-palliated Adult and Adolescent Subjects

NCT03775421 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT03775421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03775421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center, Single-arm, Open-label Long-term Study Assessing the Safety, Tolerability, and Effectiveness of Macitentan in Fontan-palliated Adult and Adolescent Subjects
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Terminated
Start date
April 11, 2019
Completion date
January 18, 2022
Enrollment
112 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease with fontan circulation